Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
A total of 41 CHH patients aged between 12 and 18 years were enrolled in the current study from 2008 to 2019 in the Beijing Children's Hospital. The GnRH pump therapy has been used since 2008 and the hCG/hMG regimen started in 2016. We developed the treatment regimen by considering the average age of Chinese juvenile spermatorrhea (13–14 years)[15,16] as well as the expert consensus on the diagnosis and treatment of idiopathic hypogonadotropic hypogonadism.[5] Thus, administration of hCG/hMG began at an age older than 12 years and at a bone age (BA) of 12 years.
Copyright and License information: ©2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
